Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] · 2026
Dermal Fillers in Skin of Color: Safety Considerations, Cultural Perspectives, and Patient-Centered Approaches.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nwaopara Amanda U, Alexis Andrew F, Burgess Cheryl M
Аннотация
BACKGROUND: Patients with skin of color make up a growing share of aesthetic dermatology practice, yet evidence guiding filler treatment in this population remains limited.
OBJECTIVE: To review the evidence on dermal filler treatment in patients with skin of color, emphasizing safety, treatment planning, and patient-centered care.
METHODS AND MATERIALS: A narrative review of PubMed/MEDLINE was performed, focusing on filler safety and efficacy in Fitzpatrick skin types (FST) IV-VI, biologic characteristics of skin of color, and population-specific aesthetic considerations.
RESULTS: Hyaluronic acid fillers have the strongest evidence base in higher Fitzpatrick phototypes; biostimulatory fillers, particularly calcium hydroxylapatite, show favorable safety data, although evidence remains limited for poly-l-lactic acid. Key considerations include increased risk of postinflammatory hyperpigmentation, differences in recognizing vascular occlusion, and a theoretical, not clinically observed, predisposition to hypertrophic scarring and keloid formation. Treatment goals are often shaped by patient preferences regarding ethnic preservation and facial identity.
CONCLUSION: Dermal filler treatment in patients with skin of color can be performed safely and effectively when guided by an understanding of melanin-rich skin biology, population-specific aging patterns, and patient-defined aesthetic goals; additional studies in higher Fitzpatrick phototypes are needed.
OBJECTIVE: To review the evidence on dermal filler treatment in patients with skin of color, emphasizing safety, treatment planning, and patient-centered care.
METHODS AND MATERIALS: A narrative review of PubMed/MEDLINE was performed, focusing on filler safety and efficacy in Fitzpatrick skin types (FST) IV-VI, biologic characteristics of skin of color, and population-specific aesthetic considerations.
RESULTS: Hyaluronic acid fillers have the strongest evidence base in higher Fitzpatrick phototypes; biostimulatory fillers, particularly calcium hydroxylapatite, show favorable safety data, although evidence remains limited for poly-l-lactic acid. Key considerations include increased risk of postinflammatory hyperpigmentation, differences in recognizing vascular occlusion, and a theoretical, not clinically observed, predisposition to hypertrophic scarring and keloid formation. Treatment goals are often shaped by patient preferences regarding ethnic preservation and facial identity.
CONCLUSION: Dermal filler treatment in patients with skin of color can be performed safely and effectively when guided by an understanding of melanin-rich skin biology, population-specific aging patterns, and patient-defined aesthetic goals; additional studies in higher Fitzpatrick phototypes are needed.